'Orvirem' malakeke. Na Ke Kumu no ka hoʻohana

Malakeke "Orvirem" (no ka keiki) ua manaoia lawa pono ka mea, e hoʻopau i nā symptoms o SARS a me ka maʻi palū. E like me nā mākua i aku nei au i ka lāʻau o ka hoʻokō oi loa i loko o ke kuʻina kakahiaka o ka maʻi. Ma hope o nā eaia ia hakumakuma o ke kiekie ana wela. Ka lāʻau "Orvirem" (no ka mea, na keiki) (manao o na makua a me ka poe akamai i hoopaa ia) ua pono tolerated a adverse reactions i lapaʻau, e like me ka rula, 'aʻole e ala mai oe.

Ke lapaau i maʻi palū, a me antiviral 'ole. ʻeleu 'Oponopono - rimantadine hydrochloride. Kaʻeleu ke keʻena i ka hopena maikaʻi ia ma ka keʻano o ka hanaʻana o nā'ōlelo, nā'ōlelo o nā mea hoʻomaʻi. Mea hōʻike i ka 'eleu he lālā o ka lapaʻau lapaau "Orvirem" ka poʻea pau i ka kokololio emi ana i loko o ka nui o symptoms. Ke k Hiki ke hoʻohana i ke kāohi ana, e emi i ka mea hiki wale mai.

Medicine "Orvirem" kauoha no ka hoʻohana 'e waiho i loko o ke kahua o ka hoʻonaʻauao kakahiaka o ka maʻi palū A-type (oi A2) a me B-type. Ka lāʻau 'Ua manao ia no nā mea maʻi mai ka makahiki i ka makahiki he umikumamaha.

A teaspoon o ka malakeke he umi milligrams oʻeleu 'Oponopono (rimantadine hydrochloride) a me excipients: hoomaemaeia ka wai, E 122, paʻakai alginate, kōpaʻa.

Ke peculiarity o ka lāʻau i loko o ka maopopo 'ole. Rimantadine lātoma kau ma luna o ka'ōpū mai o ka paʻakai alginate. Penei, he ana holo o ka lāʻau ma ka hookuu iho kona kaʻawahia. Malama aku hookuu paipai 'ia kaʻaʻahu kahe o ke koko. Ma ka Iaʻano papa hana o ka hana a me ka hoʻokāʻoi 'pharmacokinetics o ka lāʻau.

Me ka malakeke "Orvirem" manual ia kekahi e inu ma hope o kaʻai. Ka lāʻau 'ua holoi ia me ka wai.

No ka prophylactic hana like me na kēia mau laʻau heluna regimen:

• hoʻomanawanui iki mai mai kekahi i ekolu makahiki ua kuhikuhi, he umi ka pono;
• mai ekolu i ehiku - he umikumamalima;
• mai ehiku i ka umikumamaha - he iwakalua ka pono.

Lālau aʻela ia i ka lāʻau, hoʻokahi nō ka lā. E hoomau malakeke Kāohi "Orvirem" manual ia kekahi no he umi a me na la he umikumamalima.

Lapaʻau a mai lawe e kekahi noaia.

Children mai i ka makahiki ekolu i ka lā mua o ka hoakaka ia 10 mlʻekolu manawa i loko o ka lua a me ke kolu o ka lā - palua, i ka hā o ka lā - kekahi manawa.

Hoʻomanawanui iki mai i ka ehiku makahiki koho umikumamalima ka pono. Ma ka lā mua ekolu anuu i loko o ka lua, a me ka kolu - ma mau anuu. Ma ka hā o ka lā - hoʻokahi koe.

Nā mea maʻi, a heʻumikumamāhā i ka lā mua ua paipai i 15 ml eha manawa i loko o ka lua a me ke kolu o ka lā - nā manawa i ka iwakalua ka pono, i ka hā o ka lā - hookahi me 20 ml.

I ka lā e ole lawe oi aku mamua o elima milligrams no kilogram o ke kino ke kaumaha.

I ka wā mawaena ma waena o noi e ia ma ka liʻiliʻi loa, eha hora.

Ma hope o kēlā me kēia hoʻohana o ka lāʻau "Orvirem" manual ia kekahi e holoi i ka'ā'ī o ka hue ma luna o ka waho. Ka uhi E e makaʻeo paa.

I kauoha mai ai i ka lāʻau no nā keiki me nā mimikō ë he mähele wale i ka lapaau he kōpaʻa.

Contraindicated ka lapaʻauʻia "Orvirem" me ka hakuʻala a ake mai i loko o ka huʻi a maʻi pae. 'Aʻole prescribers thyrotoxicosis, kanaka intolerances, na keiki ma lalo o hoʻokahi makahiki. E ho ohana i ka "Orvirem" hapai a me ka lactating understudied. Ma pili ana me keia k ua i paipai i lactation a me ka hāpai keiki.

E e hoʻohana me ka mālama nui i loko o epilepsy.

ʻano I ka loaa ana "Orvirem" hiki undesirable loa. Ma kekahi mau hihia, e 'ike abdominal eha, bloating, a nausea. Kākaʻikahi ka ia e moe me na haunaele, pōniuniu, hoʻopōʻino lehulehu, headache.

I loko nō o ka helu 'ano nui o ka maikaʻi hōʻike manaʻo mua ka hoʻohana' ana i ka lāʻau "Orvirem" E kipa i ke kauka.